| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $182,812,877 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG064234 | Regulation of Microglial Activation State by a Lipid Transporter | 001 | 3 | NIH | 4/29/2022 | $37,482 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG064234 | Regulation of Microglial Activation State by a Lipid Transporter | 000 | 3 | NIH | 12/8/2021 | $337,333 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI143690 | Biogenesis and Function of Streptococcus Pyogenes Cell Wall | 000 | 3 | NIH | 11/23/2021 | $380,280 |
| | 2022 | 2022 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | U1Z33331 | Rural Health and Economic Analysis Program | 00 | 4 | HRSA | 7/19/2022 | $225,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | D5837582 | Residency Training in Primary Care | 01 | 3 | HRSA | 8/31/2022 | $0 |
| | 2022 | 2022 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | D5837582 | Residency Training in Primary Care | 00 | 3 | HRSA | 5/12/2022 | $451,136 |
| | 2022 | 2022 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | H3G45783 | Flex Rural Veterans Health Access Program | 00 | 1 | HRSA | 6/24/2022 | $299,999 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HD097675 | Neurotensin: A Novel Mediator of Ovulation | 000 | 4 | NIH | 7/1/2022 | $650,389 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG068215 | Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease | 001 | 3 | NIH | 8/29/2022 | $153,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG068215 | Administrative Supplement to Sleep Fragmentation and Alzheimer's Disease | 000 | 3 | NIH | 4/20/2022 | $741,567 |
| | 2022 | 2022 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | H7600719 | Ryan White Part C Outpatient EIS Program | 01 | 21 | HRSA | 7/8/2022 | $517,993 |
| | 2022 | 2022 | University Of Kentucky Research Foundation, The | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | H7600719 | Ryan White Part C Outpatient EIS Program | 00 | 21 | HRSA | 2/17/2022 | $172,665 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01HL152392 | Kentucky Network for Innovation & Commercialization (?KYNETIC?) | 001 | 4 | NIH | 8/18/2022 | $66,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01HL152392 | Kentucky Network for Innovation & Commercialization (?KYNETIC?) | 001 | 4 | NIH | 8/18/2022 | $103,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01HL152392 | Kentucky Network for Innovation & Commercialization (?KYNETIC?) | 001 | 4 | NIH | 8/18/2022 | $56,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01HL152392 | Kentucky Network for Innovation & Commercialization (?KYNETIC?) | 001 | 4 | NIH | 8/18/2022 | $723,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01HL152392 | Kentucky Network for Innovation & Commercialization (?KYNETIC?) | 001 | 4 | NIH | 8/18/2022 | $10,204 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI150767 | Structure and function of Burkholderia contact-dependent growth inhibition (CDI) systems | 000 | 3 | NIH | 8/19/2022 | $375,308 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA028246 | Cross-Tailoring Integrative Alcohol and Risky Sex Feedback for College Students: A Hybrid Type 1 Effectiveness-Implementation Trial | 001 | 2 | NIH | 6/22/2022 | $67,876 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA028246 | Cross-Tailoring Integrative Alcohol and Risky Sex Feedback for College Students: A Hybrid Type 1 Effectiveness-Implementation Trial | 000 | 2 | NIH | 1/31/2022 | $610,888 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA043938 | Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use | 000 | 5 | NIH | 5/18/2022 | $574,367 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS102196 | RIT1-mediated Protection following Traumatic Brain Injury | 001 | 5 | NIH | 3/28/2022 | $50,901 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS102196 | RIT1-mediated Protection following Traumatic Brain Injury | 000 | 5 | NIH | 1/26/2022 | $458,098 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 000 | 5 | NIH | 5/4/2022 | $98,051 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL124015 | Latexin function in the maintenance and regeneration of the hematopoietic system | 001 | 7 | NIH | 7/15/2022 | $381,679 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK095662 | The Role of Crypt Fissioning in IBD Ulcer Healing | 000 | 11 | NIH | 4/14/2022 | $662,758 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG026307 | Self-Regulation and Brain and Cognitive Health in Older Adults | 000 | 15 | NIH | 5/13/2022 | $637,768 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA266579 | Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy | 000 | 1 | NIH | 6/21/2022 | $445,226 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA057686 | Fast and fine: NLP methods for near real-time and fine-grained overdose surveillance | 000 | 1 | NIH | 9/16/2022 | $1,244,685 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG078601 | Novel experimental models to study the effect of extracellular vesicles on neurons | 000 | 1 | NIH | 8/16/2022 | $420,750 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA057686 | Fast and fine: NLP methods for near real-time and fine-grained overdose surveillance | 001 | 1 | NIH | 9/26/2022 | $100,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL162463 | Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes | 001 | 1 | NIH | 6/24/2022 | $716 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL162463 | Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes | 002 | 1 | NIH | 6/24/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P01AG078116 | Strategies for targeting astrocyte reactivity in Alzheimer's disease and related dementias | 000 | 1 | NIH | 8/31/2022 | $4,222,772 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21DA055028 | Dealers, Detectives, and People Who Use Drugs: Triangulating Perspectives to Understand COVID-19?s Impact on the Rural Appalachian Drug Market and Mitigate Downstream Overdose Risk | 000 | 1 | NIH | 8/8/2022 | $229,061 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL162463 | Targeting The GLP-1 Receptor As New Chronotherapy Against Nondipping Blood Pressure In Diabetes | 000 | 1 | NIH | 11/27/2021 | $34,778 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AI129382 | Autumn Immunology Conference | 000 | 4 | NIH | 10/19/2021 | $12,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | TL1TR001997 | NRSA Training Core | 000 | 6 | NIH | 7/25/2022 | $41,492 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG062550 | Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease? | 001 | 4 | NIH | 5/6/2022 | $57,466 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG062550 | Changing the energy substrate balance: Does APOE2 promote glucose usage to protect from Alzheimer's Disease? | 000 | 4 | NIH | 5/5/2022 | $436,980 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S Limestone 109 Kinkead Hall | Lexington | KY | 40526-0001 | FAYETTE | USA | U60OH008483 | Kentucky Occupational Safety and Health Surveillance Program | 00 | 17 | CDC | 8/22/2022 | $481,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K22CA258678 | Admixture mapping of mosaic copy number alterations for identification of cancer drivers | 000 | 1 | NIH | 4/12/2022 | $177,806 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 001 | 11 | NIH | 6/17/2022 | $498,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 003 | 11 | NIH | 9/8/2022 | $498,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 002 | 11 | NIH | 8/25/2022 | $171,892 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 003 | 11 | NIH | 9/8/2022 | -$498,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K12DA035150 | Kentucky BIRCWH Program: Training the Next Generation of Women's Health Scholars | 001 | 11 | NIH | 6/17/2022 | $150,000 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR071398 | Mechanistic assessment of blood flow restricted training for an ACL injury | 000 | 5 | NIH | 7/22/2022 | $493,533 |
| | 2022 | 2022 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE 109 KINKEAD HALL | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13DC016831 | International Society for Neurogastronomy Symposium | 000 | 6 | NIH | 8/8/2022 | $40,000 |
|
